Institutional investors purchased a net $7.0 million shares of ILMN during the quarter ended December 2015 and now own 101.93% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE RETIREMENT SYSTEMS OF ALABAM... Bought 110.4 Thousand shares of Illumina Inc
ETHENEA INDEPENDENT INVESTORS SA Bought 100.0 Thousand shares of Illumina Inc